INS and obesity disorder: There are several antidiabetic reports of chlorogenic (Cho et al., 2010; Meng et al., 2013) and caffeic acids (Zhao et al., 2022) used as novel insulin sensitizers; they improve glucose tolerance, insulin resistance, and cellular oxidative stress and manage obesity.